Arrowhead Pharmaceuticals Inc. News, Arrowhead Pharmaceuticals Inc. Quote, ARWR Quote

Arrowhead Pharmaceuticals Inc. (NQ:ARWR) Delayed: 86.34 -0.15 (0.17%)

Prev. Close

$86.49

Today 6M 1Y 5Y

Open

$85.87

52 Wk High

$8.22

52 Wk Low

$3.07

Day High

$86.96

Day Low

$84.20

P/E

N/A

EPS

$-1.30

Volume

757,848

Friends, Peers and Foes (?): ABBV, SUPN, ARGX, BBIO, CGON (more...)

ALERTS | RSS

Sep 1, 2026 09:07 AM Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
Aug 31, 2026 09:21 AM Stifel Reiterates Buy Rating on Arrowhead Pharma (ARWR)
Aug 31, 2026 08:40 AM RBC Capital Reiterates Outperform Rating on Arrowhead Pharma (ARWR)
Aug 30, 2026 11:30 AM Arrowhead's plozasiran cuts pancreatitis events 78% in Phase 3 data
Aug 30, 2026 11:30 AM Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
Aug 24, 2026 07:30 AM Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress
Aug 20, 2026 05:26 PM Form 4 ARROWHEAD PHARMACEUTICAL For: Aug 18 Filed by: OLUKOTUN ADEOYE Y
Aug 20, 2026 05:22 PM Form 4 ARROWHEAD PHARMACEUTICAL For: Aug 18 Filed by: PERRY MICHAEL S
Aug 18, 2026 05:34 PM Form 144 ARROWHEAD PHARMACEUTICAL Filed by: OLUKOTUN ADEOYE Y
Aug 18, 2026 05:25 PM Form 144 ARROWHEAD PHARMACEUTICAL Filed by: PERRY MICHAEL S

Entities mentioned with ARWR

View All Entities